Skip to main content
TipRanks
Go Ultimate75% OFF

Insmed (IM8N) Stock Forecast & Price Target

9 Followers
See the Price Targets and Ratings of:

IM8N Analyst Ratings

Strong Buy
17Ratings
16Buy1Hold0Sell
Based on 17 analysts giving stock ratings to Insmed in the past 3 months

IM8N Stock 12 Month Forecast

€174.67▲(32.13% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Insmed in the last 3 months. The average price target is EUR 174.67 with a high forecast of EUR 200.64 and a low forecast of EUR 144.09. The average price target represents a 32.13% change from the last price of EUR 132.20.
Highest Price Target€200.64Average Price Target€174.67Lowest Price Target€144.09

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:IM8N
Price TargetArticle
Bank of America Securities€186.96buy41.42%UpsideReiterated11/20/26
Mizuho Securities€144.09buy9.00%UpsideReiterated11/19/26
Raymond James―buy―Reiterated11/19/26
Guggenheim€183.31buy38.66%UpsideReiterated11/19/26
RBC Capital€177.84buy34.52%UpsideReiterated11/17/26
Morgan Stanley€194.25buy46.94%UpsideReiterated11/13/26
Evercore ISI€155.04buy17.27%UpsideReiterated11/05/26
H.C. Wainwright€200.64buy51.77%UpsideInitiated11/04/26
BMO Capital€175.10buy32.45%UpsideReiterated11/02/26
Barclays€188.78buy42.80%UpsideReiterated11/02/26
Leerink Partners Analyst forecast on DE:IM8NUnknown AnalystNot RankedLeerink Partners€191.52→€180.57buy36.59%UpsideReiterated11/02/26
UBS€156.86buy18.65%UpsideReiterated10/30/26
Goldman Sachs€171.45→€176.92buy33.83%UpsideReiterated10/30/26
Roth MKM€180.57→€186.04buy40.73%UpsideReiterated10/29/26
Wells Fargo€154.12buy16.58%UpsideAssigned10/13/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
IMUXImmunic
MDWDMediwound
PTGXProtagonist Therapeutics
KRSAKorsana Biosciences
AXGNAxoGen

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Insmed

3 Months
Jessica Fye
Jessica FyeJ.P. Morgan
Success Rate16/22 ratings generated profit
73%
Average Return
+22.36%

Copying Jessica Fye's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +22.36% per trade.

1 Year
Tiago Fauth
Tiago FauthRaymond James
Success Rate16/19 ratings generated profit
84%
Average Return
+80.11%

Copying Tiago Fauth's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +80.11% per trade.

2 Years
Jessica Fye
Jessica FyeJ.P. Morgan
Success Rate21/22 ratings generated profit
95%
Average Return
+103.66%

Copying Jessica Fye's trades and holding each position for 2 Years would result in 95.45% of your transactions generating a profit, with an average return of +103.66% per trade.

IM8N Analyst Recommendation Trends

020406080Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for IM8N
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy5146424036
Buy81415126
Hold00011
Sell00000
Strong Sell00000
total5960575343

In the current month, IM8N has received 42 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IM8N average Analyst price target in the past 3 months is 174.67.

IM8N Financial Forecast

€-3€-2€-1€0€1Q1 2026Q3 2026Q4 2026
High€0.15
Consensus€-0.28
Low€-0.81

IM8N Earnings Forecast

Next quarter’s earnings estimate for IM8N is -EUR 0.28 with a range of -EUR 0.81 to EUR 0.15. The previous quarter’s EPS was -EUR 0.42. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€240M€327.3M€414.5M€501.8M€589.1MQ1 2026Q3 2026Q4 2026
High€589M
Consensus€549M
Low€514M

IM8N Sales Forecast

Next quarter’s sales forecast for IM8N is EUR 549.16M with a range of EUR 513.90M to EUR 589.08M. The previous quarter’s sales results were EUR 476.99M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

IM8N Stock Forecast FAQ

What is DE:IM8N’s average 12-month price target, according to analysts?
Based on analyst ratings, Insmed’s 12-month average price target is €174.67.
What is DE:IM8N’s upside potential, based on the analysts’ average price target?
Insmed has 32.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Insmed a Buy, Sell or Hold?
Insmed has a consensus rating of Strong Buy, which is based on 16 buy ratings, 1 hold ratings and 0 sell ratings.
What is Insmed’s share price target?
The average share price target for Insmed is €174.67. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €200.64, and the lowest forecast is €144.09. The average share price target represents a 32.13% increase from the current price of €132.2.
What do analysts say about Insmed?
Insmed’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Insmed?
To buy shares of DE:IM8N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.